MoonLake Immunotherapeutics (MLTX)
41.00
-0.77
(-1.84%)
USD |
NASDAQ |
Apr 30, 16:00
41.00
0.00 (0.00%)
After-Hours: 20:00
MoonLake Immunotherapeutics Total Liabilities (Quarterly): 13.05M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.05M |
| September 30, 2023 | 10.58M |
| June 30, 2023 | 7.511M |
| March 31, 2023 | 7.685M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.077M |
| September 30, 2022 | 6.024M |
| June 30, 2022 | 3.876M |
| December 31, 2021 | 21.33M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.876M
Minimum
Jun 2022
21.33M
Maximum
Dec 2021
9.766M
Average
7.881M
Median
Total Liabilities (Quarterly) Benchmarks
| Qiagen NV | 2.307B |
| LENZ Therapeutics Inc | -- |
| AC Immune SA | 26.40M |
| CRISPR Therapeutics AG | 346.77M |
| Addex Therapeutics Ltd | 4.163M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 526.54M |
| Shareholders Equity (Quarterly) | 495.68M |